Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ICER Report Assumes $2.8m Price For Libmeldy As Orchard Gears Up For US Debut

Jul 26 2023

• By Alaric DeArment

• Source: Shutterstock

Related Content

Bluebird Bio Withdraws Zynteglo From Germany Over Pricing

Apr 22 2021

Its Gene Therapy Roctavian Finally Approved With $2.9m Price, BioMarin Aims To Prove Doubters Wrong

Jun 30 2023

Orchard Secures New Libmeldy Price In Germany

May 05 2022

Europe: Cross-Country HTA of Gene Therapy Libmeldy Calls For Price Cut

Oct 14 2022

Related Companies

Orchard Therapeutics Limited

Genetix Biotherapeutics

BioMarin Pharmaceutical Inc.

uniQure N.V.

CSL Limited

Additional Topics

Gene Therapy Market Access Commercial Neurology BioPharmaceutical

More from Gene Therapies

More from Advanced Therapies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window